TH17-Based Vaccine Design for Prevention of Streptococcus pneumoniae Colonization

Adam, 1995, A nondegradative route for the removal of endotoxin from exopolysaccharides, Anal. Biochem., 225, 321, 10.1006/abio.1995.1161 Alexander, 1994, Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae, Infect. Immun., 62, 5683, 10.1128/iai.62.12.5683-5688.1994 Aujla, 2007, Th17 cells and mucosal host defense, Semin. Immunol., 19, 377, 10.1016/j.smim.2007.10.009 Briles, 2000, Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA, J. Infect. Dis., 182, 1694, 10.1086/317602 Briles, 2003, Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae, J. Infect. Dis., 188, 339, 10.1086/376571 Curtis, 2009, Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens, Immunology, 126, 177, 10.1111/j.1365-2567.2008.03017.x Datsenko, 2000, One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products, Proc. Natl. Acad. Sci. USA, 97, 6640, 10.1073/pnas.120163297 Datta, 2010, Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax, Proc. Natl. Acad. Sci. USA, 107, 10638, 10.1073/pnas.1002348107 Giefing, 2008, Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies, J. Exp. Med., 205, 117, 10.1084/jem.20071168 Glover, 2008, Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis, Infect. Immun., 76, 2767, 10.1128/IAI.01126-07 Huang, 2005, Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004, Pediatrics, 116, e408, 10.1542/peds.2004-2338 Lee, 2009, Intranasal delivery of cholera toxin induces th17-dominated T-cell response to bystander antigens, PLoS ONE, 4, e5190, 10.1371/journal.pone.0005190 Lipsitch, 2005, Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?, PLoS Med., 2, e15, 10.1371/journal.pmed.0020015 Lu, 2008, Interleukin-17A mediates acquired immunity to pneumococcal colonization, PLoS Pathog., 4, e1000159, 10.1371/journal.ppat.1000159 Malley, 2001, Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci, Infect. Immun., 69, 4870, 10.1128/IAI.69.8.4870-4873.2001 Malley, 2005, CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization, Proc. Natl. Acad. Sci. USA, 102, 4848, 10.1073/pnas.0501254102 Milner, 2008, Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome, Nature, 452, 773, 10.1038/nature06764 Nabors, 2000, Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules, Vaccine, 18, 1743, 10.1016/S0264-410X(99)00530-7 Nagy, E. (2010). IC47, a novel protein-based pneumococcal vaccine: from bench to the clinic. 7th International Symposium on Pneumococci and Pneumococcal Diseases. Tel Aviv, Israel. March 14–18, 2010. O'Brien, 2009, Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates, Lancet, 374, 893, 10.1016/S0140-6736(09)61204-6 O'Connor, 2010, The dual nature of T(H)17 cells: shifting the focus to function, Nat. Immunol., 11, 471, 10.1038/ni.1882 Ogunniyi, 2000, Immunization of mice with combinations of pneumococcal virulence proteins elicits enhanced protection against challenge with Streptococcus pneumoniae, Infect. Immun., 68, 3028, 10.1128/IAI.68.5.3028-3033.2000 Paton, 1991, Purification and immunogenicity of genetically obtained pneumolysin toxoids and their conjugation to Streptococcus pneumoniae type 19F polysaccharide, Infect. Immun., 59, 2297, 10.1128/iai.59.7.2297-2304.1991 Sanderson, 1994, LacZ inducible, antigen/MHC-specific T cell hybrids, Int. Immunol., 6, 369, 10.1093/intimm/6.3.369 Sanderson, 1995, Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins, Proc. Natl. Acad. Sci. USA, 92, 7217, 10.1073/pnas.92.16.7217 Singleton, 2007, Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage, JAMA, 297, 1784, 10.1001/jama.297.16.1784 Trzcinski, 2005, Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model, Infect. Immun., 73, 7043, 10.1128/IAI.73.10.7043-7046.2005 Wizemann, 2001, Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection, Infect. Immun., 69, 1593, 10.1128/IAI.69.3.1593-1598.2001 Zhang, 2008, The isolation and characterization of murine macrophages, Curr. Protoc. Immunol., 10.1002/0471142735.im1401s83